Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
25.86
+0.20 (0.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immunovant Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
207
Market Cap
3.80B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organon & Co. | 6.41B |
| Option Care Health | 4.78B |
| DENTSPLY SIRONA | 3.90B |
| ICU Medical | 2.34B |
| Haemonetics | 1.36B |
| Sotera Health Company | 1.12B |
| Prestige Consumer Healthcare | 1.11B |
| Guardant Health | 692.26M |
IMVT News
- 11 days ago - FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial - GlobeNewsWire
- 6 weeks ago - Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 7 weeks ago - Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves' Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - GlobeNewsWire
- 3 months ago - Top 2 Health Care Stocks That May Collapse This Quarter - Benzinga
- 3 months ago - Immunovant Provides Update on Graves' Disease Development Program - GlobeNewsWire
- 3 months ago - Immunovant to Host Graves' Disease Program Update on September 9, 2024 - GlobeNewsWire
- 4 months ago - Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging - Seeking Alpha
- 7 months ago - Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024 - GlobeNewsWire